Call Us + 33 1 84 88 31 00

Article D1221-65 of the French Public Health Code

When the import concerns plasma pastes or labile blood products intended for the preparation of health products, the authorisation referred to in Article D. 1221-58 is issued to the following organisations or establishments: 1° The Etablissement français du sang ; 2° The Armed Forces Blood Transfusion Centre; 3° Pharmaceutical establishments authorised in accordance with the provisions of article L. 5124-3 and manufacturing medicinal products; 4° Manufacturers of other health products…

Read More »

Article D1221-66 of the French Public Health Code

When applying for an import authorisation, the importer must certify, notwithstanding the provisions of g of Article D. 1221-61, that the samples of blood or its components, from which the product for which the import authorisation is requested was prepared, comply with the requirements of Section 2 of this chapter. Where this is not the case, and provided that it is justified, the importer must provide an undertaking stating that…

Read More »

Article D1221-66-1 of the French Public Health Code

The authorisation referred to in Article D. 1221-58 may be issued to the Etablissement Français du Sang for the importation of blood or its components intended for the preparation of labile blood products within the framework of an international agreement providing for cross-border cooperation. By way of derogation from the provisions of article D. 1221-60 and article D. 1221-61, these imports may be authorised if the blood samples or its…

Read More »

Article D1221-67 of the French Public Health Code

Notwithstanding the provisions of the first paragraph of Article D. 1221-58, the import authorisation may be issued by the Director General of the Agence nationale de sécurité du médicament et des produits de santé on the basis of a forward programme submitted by the importer. At the end of the authorisation period, the importer draws up a report on the operations carried out and the quantity imported during the period.

Read More »

Article D1221-67-1 of the French Public Health Code

By way of derogation from the provisions of the first paragraph of article D. 1221-58, when the Armed Forces Blood Transfusion Centre imports labile blood products with a view to processing them for foreign armed forces, the import authorisation is issued by the Agence nationale de sécurité du médicament et des produits de santé on the basis of a three-year programme and within the limit of a specified maximum overall…

Read More »

Article R1221-69 of the French Public Health Code

I. – Claims for compensation under the out-of-court procedure provided for in article L. 1221-14 in respect of the losses defined in the same article are addressed to the Office national d’indemnisation des accidents médicaux, des affections iatrogènes et des infections nosocomiales mentioned in article L. 1142-22. These claims for compensation shall include, in addition to the justification of the losses, the supporting documents mentioned in the second paragraph of…

Read More »

Article R1221-71 of the French Public Health Code

In order to assess the extent of the damage and determine whether it can be attributed to the accident, the Director of the Office will, if necessary, arrange for an expert opinion. The doctor responsible for carrying out the assessment is chosen, on the basis of his or her competence in the field(s) concerned, from the national list of medical accident experts referred to in article L. 1142-10 or one…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.